223 related articles for article (PubMed ID: 31244937)
1. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
[TBL] [Abstract][Full Text] [Related]
2. Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy.
Wang W; Chen K; Su Y; Zhang J; Li M; Zhou J
Biomacromolecules; 2018 Feb; 19(2):438-448. PubMed ID: 29334216
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo.
Salmasi Z; Hashemi M; Mahdipour E; Nourani H; Abnous K; Ramezani M
Biotechnol Prog; 2020 Nov; 36(6):e3025. PubMed ID: 32410328
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
6. Magnetic ternary nanohybrids for nonviral gene delivery of stem cells and applications on cancer therapy.
Huang RY; Lin YH; Lin SY; Li YN; Chiang CS; Chang CW
Theranostics; 2019; 9(8):2411-2423. PubMed ID: 31149052
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
[TBL] [Abstract][Full Text] [Related]
9. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy.
Han J; Hwang HS; Na K
Biomaterials; 2018 Nov; 182():259-268. PubMed ID: 30142525
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour.
Fakiruddin KS; Ghazalli N; Lim MN; Zakaria Z; Abdullah S
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060445
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
[TBL] [Abstract][Full Text] [Related]
13. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
[TBL] [Abstract][Full Text] [Related]
14. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.
Loebinger MR; Eddaoudi A; Davies D; Janes SM
Cancer Res; 2009 May; 69(10):4134-42. PubMed ID: 19435900
[TBL] [Abstract][Full Text] [Related]
16. Bioinspired Star-Shaped Poly(l-lysine) Polypeptides: Efficient Polymeric Nanocarriers for the Delivery of DNA to Mesenchymal Stem Cells.
Walsh DP; Murphy RD; Panarella A; Raftery RM; Cavanagh B; Simpson JC; O'Brien FJ; Heise A; Cryan SA
Mol Pharm; 2018 May; 15(5):1878-1891. PubMed ID: 29590755
[TBL] [Abstract][Full Text] [Related]
17. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.
Moniri MR; Sun XY; Rayat J; Dai D; Ao Z; He Z; Verchere CB; Dai LJ; Warnock GL
Cancer Gene Ther; 2012 Sep; 19(9):652-8. PubMed ID: 22767216
[TBL] [Abstract][Full Text] [Related]
18. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
19. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL.
Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476
[TBL] [Abstract][Full Text] [Related]
20. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy.
Zhang F; Li M; Su Y; Zhou J; Wang W
Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():208-218. PubMed ID: 27127046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
